Fermentas

Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility in Carlsbad, California

Retrieved on: 
Thursday, July 15, 2021
Companies, Thermo Fisher Scientific, Virology, Patheon, Industry economics), Thermo, Vaccine, Fisher Scientific, Mergers and acquisitions, Fermentas

WALTHAM, Mass., July 15, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.

Key Points: 
  • WALTHAM, Mass., July 15, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
  • "Demand for commercial plasmid DNA is outpacing supply as the development of transformative gene therapies and vaccines accelerates globally," said Marc N. Casper, chairman, president and chief executive officer, Thermo Fisher Scientific.
  • To celebrate the opening of the new facility, Thermo Fisher hosted a ribbon-cutting ceremony today with local government officials including U.S.
  • To learn more about Thermo Fisher's new cGMP Plasmid DNA manufacturing facility, please visit www.thermofisher.com/patheon .

Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

Retrieved on: 
Tuesday, June 8, 2021
Companies, Economy of the United States, Industry economics), Thermo Fisher Scientific, Applied Biosystems, Invitrogen, Patheon, Fisher Scientific, Thermo, Waltham, Massachusetts, Goldman Sachs, Fermentas

WALTHAM, Mass., June 8, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT).

Key Points: 
  • WALTHAM, Mass., June 8, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT).
  • You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion.
  • Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Thermo Fisher Scientific to Present at 41st Annual Cowen Healthcare Conference on March 3, 2021

Retrieved on: 
Wednesday, February 24, 2021
Companies, Economy of the United States, Industry economics), Thermo Fisher Scientific, Applied Biosystems, Invitrogen, Patheon, Thermo, Fisher Scientific, Waltham, Massachusetts, Fermentas, Pierce Biotechnology

WALTHAM, Mass., Feb. 24, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 41st Annual Cowen Healthcare Conference on Wednesday, March 3, 2021, at 10:20 a.m. (EDT).

Key Points: 
  • WALTHAM, Mass., Feb. 24, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 41st Annual Cowen Healthcare Conference on Wednesday, March 3, 2021, at 10:20 a.m. (EDT).
  • You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion.
  • Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19

Retrieved on: 
Thursday, March 26, 2020
Companies, Technology, Articles, Applied Biosystems, Thermo Fisher Scientific, Thermo, Fisher Scientific, TMO, Real-time polymerase chain reaction, Fermentas

WALTHAM, Mass., March 26, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19.

Key Points: 
  • WALTHAM, Mass., March 26, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19.
  • "The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific.
  • The Thermo Fisher test, which uses Applied Biosystems TaqPath Assay and real-time PCR technology, is designed to provide patient results within four hours of a sample being received by a lab.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion.

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19

Retrieved on: 
Thursday, March 26, 2020
Companies, Technology, Articles, Applied Biosystems, Thermo Fisher Scientific, Thermo, Fisher Scientific, TMO, Real-time polymerase chain reaction, Fermentas

WALTHAM, Massachusetts, March 26, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19.

Key Points: 
  • WALTHAM, Massachusetts, March 26, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19.
  • "The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific.
  • The Thermo Fisher test, which uses Applied Biosystems TaqPath Assay and real-time PCR technology, is designed to provide patient results within four hours of a sample being received by a lab.
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion.

Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2019 Health Care Conference on May 14, 2019

Retrieved on: 
Tuesday, May 7, 2019
Companies, Economy of the United States, Industries, Applied Biosystems, Thermo Fisher Scientific, Invitrogen, Thermo, Fisher Scientific, Waltham, Massachusetts, Navigenics, Fermentas

WALTHAM, Mass., May 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 8:40 a.m. (PT) at the Encore at the Wynn Las Vegas, Las Vegas, Nevada.

Key Points: 
  • WALTHAM, Mass., May 7, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019, at 8:40 a.m. (PT) at the Encore at the Wynn Las Vegas, Las Vegas, Nevada.
  • You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 13, 2019

Retrieved on: 
Monday, March 4, 2019
Companies, Economy of the United States, Applied Biosystems, Invitrogen, Industries, Thermo Fisher Scientific, Thermo, Fisher Scientific, Waltham, Massachusetts, Navigenics, Fermentas

WALTHAM, Mass., March 4, 2019 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019, at 8:00 a.m. (EDT) at the Loews Miami Hotel, Miami, Florida.

Key Points: 
  • WALTHAM, Mass., March 4, 2019 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Wednesday, March 13, 2019, at 8:00 a.m. (EDT) at the Loews Miami Hotel, Miami, Florida.
  • You can access the live webcast of the presentation in the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

Thermo Fisher Scientific to Present at the Jefferies 2018 London Healthcare Conference on November 14, 2018

Retrieved on: 
Wednesday, October 31, 2018
Technology, Economy of the United States, Applied Biosystems, Invitrogen, Thermo Fisher Scientific, Thermo, Fisher Scientific, Science and technology, Waltham, Massachusetts, Navigenics, Fermentas

WALTHAM, Mass., Oct. 31, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Jefferies 2018 London Healthcare Conference on Wednesday, November 14, 2018, at 10:40 a.m. (GMT) at the Waldorf Hilton, London, UK.

Key Points: 
  • WALTHAM, Mass., Oct. 31, 2018 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Jefferies 2018 London Healthcare Conference on Wednesday, November 14, 2018, at 10:40 a.m. (GMT) at the Waldorf Hilton, London, UK.
  • You can access the live webcast of the presentation in the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.

Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2018

Retrieved on: 
Tuesday, September 4, 2018
Technology, Economy of the United States, Applied Biosystems, Invitrogen, Thermo Fisher Scientific, Thermo, Fisher Scientific, Waltham, Massachusetts, Fermentas, Navigenics

WALTHAM, Mass., Sept. 4, 2018 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018, at 2:15 p.m. (ET) at the Grand Hyatt New York, New York.

Key Points: 
  • WALTHAM, Mass., Sept. 4, 2018 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018, at 2:15 p.m. (ET) at the Grand Hyatt New York, New York.
  • You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com .
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally.
  • Through our premier brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.